Press release
Impact Of Female Demographics On Migraine Drug Market Growth: Pivotal Factor Influencing Migraine Drugs Market Growth in 2025
Migraine Drugs
Migraine Drugs Market Size Growth Forecast: What to Expect by 2025?
There has been notable growth in the migraine drugs market in the past few years. The market, initially valued at $5.38 billion in 2024, is projected to expand to $5.71 billion in 2025, implying a compound annual growth rate (CAGR) of 6.2%. Factors such as developments in drug formulations, heightened awareness and diagnoses, stress and lifestyle impacts, the introduction of generic drugs, and the rise of cgrp inhibitors contribute to the growth observed in the historical period.
How Will the Migraine Drugs Market Size Evolve and Grow by 2029?
The market size of migraine drugs is positioned to witness robust expansion in the ensuing years, climbing to ""$7.08 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 5.5%. This advancement during the projection period can be credited to factors such as tailored medical treatments, telemedicine and remote healthcare consultations, healthcare regulations and insurance provisions, and the escalating worldwide migraine strain, along with combination therapies. The forecast period is also predicted to see significant trends like targeted therapies, telemedicine and remote consultations, patient-focused strategies, digital therapeutic solutions, biosimilars in migraine care, and clinical studies and trials.
View the full report here:
https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report
What Drivers Are Propelling the Growth of Migraine Drugs Market Forward?
The surge in the number of females worldwide is speculated to fuel the expansion of the market for migraine medications. The term ""female population"" pertains to all females of various age groups residing in a specific country or region at a given time. Migraines are considerably more prevalent in females than in males due to a fusion of genetic, hormonal, and environmental aspects. For instance, according to the World Population Prospects 2022 published by the United Nations, a US-based intergovernmental organization, it's estimated that the global female population will be 4.00 billion in 2022, amounting to 49.75% of the global population. It is also anticipated that the number of females will surpass males in 2049. Consequently, the escalating female population is facilitating the growth of the market for migraine medications.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Migraine Drugs Market?
Leading corporations in the migraine drugs market like Pfizer, are making concerted efforts to create innovative products, for instance, a nasal spray by the name of Zavzpret. The goal is to offer improved services to patients and secure a competitive advantage in the market. Designed specifically for adults suffering from acute migraines, with or without aura, Zavzpret becomes a tremendous achievement in migraine medication. In March 2023, the US-based pharmaceutical company, Pfizer, received approval from the Food and Drug Administration. As an approved zavegepant (CGRP receptor antagonist) nasal spray, this product is the first of its kind for acute migraine treatment. Zavzpret works by targeting the calcitonin gene-related peptide (CGRP). The endorsement of Zavzpret presents a new therapeutic option for migraine patients, especially those experience nausea and vomiting due to migraine attacks, and for those who are unable to use triptans due to cardiovascular risks.
What Are the Key Segments in the Migraine Drugs Market?
The migraine drugs market covered in this report is segmented -
1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants
2) By Route of Administration: Oral, Injectable, Other Routes
3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users
Subsegments:
1) By Triptans: Sumatriptan, Rizatriptan, Zolmitriptan, Eletriptan
2) By Beta Blockers: Propranolol, Metoprolol, Timolol
3) By Angiotensin Blockers: Candesartan, Losartan
4) By Tricyclics: Amitriptyline, Nortriptyline
5) By Anticonvulsants: Topiramate, Valproate
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13484&type=smp
Who Are the Key Players Shaping the Migraine Drugs Market's Competitive Landscape?
Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddy's Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.
What Geographic Markets Are Powering Growth in the Migraine Drugs Market?
North America was the largest region in the migraine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13484
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
#Reach Out to Us#
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Female Demographics On Migraine Drug Market Growth: Pivotal Factor Influencing Migraine Drugs Market Growth in 2025 here
News-ID: 4183153 • Views: …
More Releases from The Business Research Company
Interstitial Cystitis Drugs Market Expansion Continues, with Forecast Valuation …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Interstitial Cystitis Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size for drugs dealing with interstitial cystitis has seen considerable growth. It is estimated to expand from a value of $1.36 billion in 2024 to $1.44 billion in 2025,…
Top Market Shifts Transforming the Focal Segmental Glomerulosclerosis Drugs Mark …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Focal Segmental Glomerulosclerosis Drugs Market Through 2025?
The market for drugs dealing with focal segmental glomerulosclerosis has seen significant growth lately. Expectations are that it will climb from $15.77 billion in 2024 to $17 billion in 2025, with a compound annual growth…
Elevated Birth Defect Rates Fuel Growth In The Congenital Diaphragmatic Hernia D …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Congenital Diaphragmatic Hernia Drugs Industry Market Size Be by 2025?
The market size for drugs treating congenital diaphragmatic hernia has seen significant growth recently. The market is set to expand from $4.38 billion in 2024 to $4.69 billion in 2025, with a compound annual growth rate…
Bronchodilators Market Expected to Achieve 6.3% CAGR by 2029: Growth Forecast In …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Bronchodilators Market Size By 2025?
The market size for bronchodilators has seen significant growth in the past few years. The market is expected to increase from $32.93 billion in 2024 to $35.31 billion in 2025, registering a compound annual growth rate (CAGR) of 7.2%. The…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
